A monoclonal antibody-cobra venom factor conjugate increases the tumor-specific uptake of a 99mTc-labeled anti-carcinoembryonic antigen antibody by a two-step approach.

Abstract:

:Monoclonal antibodies (mabs) have considerable potential for specific cancer treatment. However, due to the antigen heterogeneity and especially the low uptake in solid tumors, mabs have not been used successfully in most clinical trials to date. This study investigates the effects of a mab-cobra venom factor (CVF) conjugate in vitro and in vivo in an orthotopic pancreatic cancer model using nude rats. CVF, a nontoxic glycoprotein from cobra venom, permanently activates the alternative pathway of complement. Coupled to a mab with tumor-binding properties, the complement activation can be targeted to the tumor tissue. We studied the activity of a mab CA19-9-CVF conjugate with the human pancreatic cancer cells PancTu I. PancTu I cells express the complement resistance factors CD46, CD55, and CD59, as we demonstrated by immunostaining, an observation that may explain the lack of cytotoxicity of the CA19-9-CVF conjugate. However, using ELISA, Western blot, and immunostaining, we showed that CA19-9-CVF activates the complement cascade, including the release of the anaphylatoxin C3a, a mediator of an inflammatory reaction. The in vivo studies of CA19-9-CVF-treated nude rats showed an increased tumor infiltration by natural killer cells and macrophages. The tumor uptake of 99Tc-labeled anti-carcinoembryonic antigen antibody was increased approximately 2-fold in rats pretreated with 70 micrograms of CA19-9-CVF, compared to animals that received an equimolar mixture of noncoupled mab and CVF. This study indicates the value of mab-CVF conjugates in adjuvant immunotherapy. mab-CVF conjugates might be useful in pretargeting approaches by increasing the uptake of a therapeutic mab.

journal_name

Cancer Res

journal_title

Cancer research

authors

Juhl H,Sievers M,Baltzer K,Helmig F,Wolf H,Brenner W,Kalthoff H

subject

Has Abstract

pub_date

1995-12-01 00:00:00

pages

5749s-5755s

issue

23 Suppl

eissn

0008-5472

issn

1538-7445

journal_volume

55

pub_type

杂志文章
  • The 104-123 amino acid sequence of the beta-domain of von Hippel-Lindau gene product is sufficient to inhibit renal tumor growth and invasion.

    abstract::The von Hippel-Lindau (VHL) tumor suppressor gene is mutated in patients with VHL disease and in the majority of patients with sporadic renal cell carcinomas (RCCs). RCCs are dependent on insulin-like growth factor-1 receptor-mediated signaling for tumor growth and invasion in vivo. Reintroduction of the VHL gene prod...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Datta K,Sundberg C,Karumanchi SA,Mukhopadhyay D

    更新日期:2001-03-01 00:00:00

  • Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene.

    abstract::Approximately 10% of gastric adenocarcinomas worldwide are associated with human EBV. These carcinomas generally do not express the latent membrane protein 1 (LMP1), the major known EBV oncogene. Recently, another EBV gene [ie., BARF1 (BamHI A rightward open reading frame)] was shown to have transforming and immortali...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: zur Hausen A,Brink AA,Craanen ME,Middeldorp JM,Meijer CJ,van den Brule AJ

    更新日期:2000-05-15 00:00:00

  • Gene transfer of thromboxane A(2) synthase and prostaglandin I(2) synthase antithetically altered tumor angiogenesis and tumor growth.

    abstract::Cyclooxygenase, involved in tumor growth and angiogenesis, converts arachidonic acid to prostaglandin (PG)H(2), which is immediately converted to bioactive prostanoids including PGE(2), PGD(2), thromboxane (TX)A(2) and PGI(2). To test the hypothesis that changes in the prostanoid profile alter cancer growth, we transd...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Pradono P,Tazawa R,Maemondo M,Tanaka M,Usui K,Saijo Y,Hagiwara K,Nukiwa T

    更新日期:2002-01-01 00:00:00

  • Bcl-2 antisense oligodeoxynucleotide therapy of Epstein-Barr virus-associated lymphoproliferative disease in severe combined immunodeficient mice.

    abstract::Bcl-2 is upregulated by Epstein-Barr virus (EBV) in immortalized lymphoblastoid (LCL) B cells and is expressed in the majority of EBV-associated posttransplant lymphoproliferative disorders (PTLDs). Given the antiapoptotic function and chemoprotective effects of Bcl-2, it represents a rational target for modulation us...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Guinness ME,Kenney JL,Reiss M,Lacy J

    更新日期:2000-10-01 00:00:00

  • Regulation of expression of BIK proapoptotic protein in human breast cancer cells: p53-dependent induction of BIK mRNA by fulvestrant and proteasomal degradation of BIK protein.

    abstract::Induction of mRNA for BIK proapoptotic protein by doxorubicin or gamma-irradiation requires the DNA-binding transcription factor activity of p53. In MCF7 cells, pure antiestrogen fulvestrant also induces BIK mRNA and apoptosis. Here, we provide evidence that, in contrast to doxorubicin or gamma-irradiation, fulvestran...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-3696

    authors: Hur J,Bell DW,Dean KL,Coser KR,Hilario PC,Okimoto RA,Tobey EM,Smith SL,Isselbacher KJ,Shioda T

    更新日期:2006-10-15 00:00:00

  • Factors influencing nonleukemic death in refractory anemia, refractory anemia with ring sideroblasts, and refractory anemia with excess of blasts.

    abstract::The association between nonleukemic death and various features recorded at presentation in patients with refractory anemia (RA), RA with ring sideroblasts, and RA with excess of blasts was analyzed in 251 patients using the proportional hazards model. Features associated with higher nonleukemic death rates were: 1% or...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Oguma S,Yoshida Y,Uchino H,Maekawa T

    更新日期:1987-07-01 00:00:00

  • Novel gene sequences expressed by human melanoma cells identified by molecular subtraction.

    abstract::Despite the variety of approaches used, only a limited number of tumor-associated antigens have been described for each histological type of tumor. In this report, we present a new strategy involving molecular subtraction to identify novel melanoma-associated gene sequences. Toward this end, 156 complementary DNA clon...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hutchins JT,Deans RJ,Mitchell MS,Uchiyama C,Kan-Mitchell J

    更新日期:1991-03-01 00:00:00

  • Cysteine catabolism: a novel metabolic pathway contributing to glioblastoma growth.

    abstract::The relevance of cysteine metabolism in cancer has gained considerable interest in recent years, largely focusing on its role in generating the antioxidant glutathione. Through metabolomic profiling using a combination of high-throughput liquid and gas chromatography-based mass spectrometry on a total of 69 patient-de...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-1423

    authors: Prabhu A,Sarcar B,Kahali S,Yuan Z,Johnson JJ,Adam KP,Kensicki E,Chinnaiyan P

    更新日期:2014-02-01 00:00:00

  • Effects of 5-mercapto-2'-deoxyuridine on the incorporation of nucleosides into RNA and DNA in a primary lymphocyte culture system.

    abstract::The effects of 5-mercapto-2'-deoxyuridine (MUdr) on DNA synthesis in a primary murine spleen lymphocyte culture system stimulated by phytohemagglutinin (PHA) were studied. Inhibition of thymidine incorporation into acid insoluble nucleic acid material was 50% at 0.5 mM MUdR concentration, while inhibition of deoxyurid...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bogyo D,Bardos TJ,Chmielewicz ZF

    更新日期:1976-09-01 00:00:00

  • Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy.

    abstract::Immune checkpoint therapies exhibit impressive efficacy in some patients with melanoma or lung cancer, but the lack of response in most cases presses the question of how general efficacy can be improved. In addressing this question, we generated a preclinical tumor model to study anti-PD-1 resistance by in vivo passag...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-15-3142

    authors: Wang X,Schoenhals JE,Li A,Valdecanas DR,Ye H,Zang F,Tang C,Tang M,Liu CG,Liu X,Krishnan S,Allison JP,Sharma P,Hwu P,Komaki R,Overwijk WW,Gomez DR,Chang JY,Hahn SM,Cortez MA,Welsh JW

    更新日期:2017-02-15 00:00:00

  • Suppressive effect of basic fibroblast growth factor on transendothelial emigration of CD4(+) T-lymphocyte.

    abstract::The effect of basic fibroblast growth factor (b-FGF), one of the commonest angiogenic factors in various cancer types, on lymphocyte adhesion and transmigration across the endothelial cell monolayer was investigated using human umbilical vein-derived endothelial cells (HUVEC) and type I collagen gel. Forty-eight h exp...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kitayama J,Nagawa H,Yasuhara H,Tsuno N,Kimura W,Shibata Y,Muto T

    更新日期:1994-09-01 00:00:00

  • Involvement of RNA helicases p68 and p72 in colon cancer.

    abstract::The homologous proteins p68 and p72 are members of the DEAD box family of RNA helicases. Here, we show that expression of both of these helicases strongly increases during the polyp-->adenoma-->adenocarcinoma transition in the colon. Furthermore, p68 and p72 form complexes with beta-catenin and promote the ability of ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-4652

    authors: Shin S,Rossow KL,Grande JP,Janknecht R

    更新日期:2007-08-15 00:00:00

  • Significance of purine salvage in circumventing the action of antimetabolites in rat hepatoma cells.

    abstract::The flux activities of de novo and salvage purine synthesis were compared in rat hepatoma 3924A cells in various growth phases. The initial rate assays of [14C]adenine, [14C]hypoxanthine, and [14C]guanine incorporation yielded Michaelis-Menten kinetics with Kms of 5, 7, and 7 microM, respectively. After replating plat...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Natsumeda Y,Ikegami T,Olah E,Weber G

    更新日期:1989-01-01 00:00:00

  • Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors.

    abstract::Molecules that physiologically control cell proliferation are often produced locally in tissues and are rapidly destroyed when they enter circulation. This allows local effects while avoiding interference with other systems. Unfortunately, it also limits the therapeutic use of these molecules via systemic delivery. We...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Studeny M,Marini FC,Champlin RE,Zompetta C,Fidler IJ,Andreeff M

    更新日期:2002-07-01 00:00:00

  • Nerve growth factor stimulation of mouse embryonal carcinoma cell migration.

    abstract::Embryonal carcinoma cells localize to a specific array of target tissues including the male submaxillary gland following intracardiac injection. These target tissues or conditioned medium derived from them have been shown to stimulate the in vitro migration of embryonal carcinoma cells. Here we show that in vitro migr...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kahan BW,Kramp DC

    更新日期:1987-12-01 00:00:00

  • Effects of serum concentration on the expression of carcinogen-induced transformation in the C3H/10T1/2 CL8 cell line.

    abstract::The C3H/10T1/2 CL8 cell line (10T1/2) is being widely used as a quantitative assay system for chemical and physical carcinogens. 10T1/2 cells, but not their transformed counterparts, exhibit a decreased final saturation density with decreasing serum concentration. Exposure of carcinogen-treated cultures to 5% serum 8 ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bertram JS

    更新日期:1977-02-01 00:00:00

  • Single-strand DNA-binding protein SSB1 facilitates TERT recruitment to telomeres and maintains telomere G-overhangs.

    abstract::Proliferating mammalian stem and cancer cells express telomerase [telomerase reverse transcriptase (TERT)] in an effort to extend chromosomal G-overhangs and maintain telomere ends. Telomerase-expressing cells also have higher levels of the single-stranded DNA-binding protein SSB1, which has a critical role in DNA dou...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-2289

    authors: Pandita RK,Chow TT,Udayakumar D,Bain AL,Cubeddu L,Hunt CR,Shi W,Horikoshi N,Zhao Y,Wright WE,Khanna KK,Shay JW,Pandita TK

    更新日期:2015-03-01 00:00:00

  • Intestinal intraepithelial lymphocytes bind to colon cancer cells by HML-1 and CD11a.

    abstract::Human intraepithelial lymphocytes (IEL), predominantly CD8+ T-lymphocytes located between intestinal epithelial cells (EC), may represent the first-line immune defense against colon cancer. The mechanism by which IEL bind to the colon cancer line, DLD-1, was evaluated. A larger fraction of IEL than peripheral blood mo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Roberts AI,O'Connell SM,Ebert EC

    更新日期:1993-04-01 00:00:00

  • Loss of TRIM29 Alters Keratin Distribution to Promote Cell Invasion in Squamous Cell Carcinoma.

    abstract::: TRIM29 (tripartite motif-containing protein 29) is a TRIM family protein that has been implicated in breast, colorectal, and pancreatic cancers. However, its role in stratified squamous epithelial cells and tumors has not been elucidated. Here, we investigate the expression of TRIM29 in cutaneous head and neck squam...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-18-1495

    authors: Yanagi T,Watanabe M,Hata H,Kitamura S,Imafuku K,Yanagi H,Homma A,Wang L,Takahashi H,Shimizu H,Hatakeyama S

    更新日期:2018-12-15 00:00:00

  • Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo.

    abstract::Cancer may arise from a cancer stem/progenitor cell that shares characteristics with its normal counterpart. We report the reconstitution of the original human prostate cancer specimen from epithelial cell lines (termed HPET for human prostate epithelial/hTERT) derived from this sample. These tumors can be described i...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-4608

    authors: Gu G,Yuan J,Wills M,Kasper S

    更新日期:2007-05-15 00:00:00

  • Identification of compounds selectively killing multidrug-resistant cancer cells.

    abstract::There is a great need for the development of novel chemotherapeutic agents that overcome the emergence of multidrug resistance (MDR) in cancer. We catalogued the National Cancer Institute's DTP drug repository in search of compounds showing increased toxicity in MDR cells. By comparing the sensitivity of parental cell...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-2422

    authors: Türk D,Hall MD,Chu BF,Ludwig JA,Fales HM,Gottesman MM,Szakács G

    更新日期:2009-11-01 00:00:00

  • Sustained small interfering RNA delivery by mesoporous silicon particles.

    abstract::RNA interference (RNAi) is a powerful approach for silencing genes associated with a variety of pathologic conditions; however, in vivo RNAi delivery has remained a major challenge due to lack of safe, efficient, and sustained systemic delivery. Here, we report on a novel approach to overcome these limitations using a...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-3931

    authors: Tanaka T,Mangala LS,Vivas-Mejia PE,Nieves-Alicea R,Mann AP,Mora E,Han HD,Shahzad MM,Liu X,Bhavane R,Gu J,Fakhoury JR,Chiappini C,Lu C,Matsuo K,Godin B,Stone RL,Nick AM,Lopez-Berestein G,Sood AK,Ferrari M

    更新日期:2010-05-01 00:00:00

  • Micropthalmia transcription factor: a new prognostic marker in intermediate-thickness cutaneous malignant melanoma.

    abstract::Micropthalmia transcription factor (Mitf) is involved in melanocyte development and differentiation. The current study was undertaken to determine whether there is a relationship between Mitf expression and survival in patients with intermediate-thickness (1.0-4.0 mm) melanoma. Original paraffin blocks or slides of th...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Salti GI,Manougian T,Farolan M,Shilkaitis A,Majumdar D,Das Gupta TK

    更新日期:2000-09-15 00:00:00

  • Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft.

    abstract::In the present study, we examined hemodynamics in vasculogenic mimicry (VM) and angiogenesis of inflammatory breast cancer (IBC) xenografts (WIBC-9), having previously reported on the unique histological features and molecular basis of these processes (K. Shirakawa et al., Cancer Res., 61: 445-451, 2001). Histological...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Shirakawa K,Kobayashi H,Heike Y,Kawamoto S,Brechbiel MW,Kasumi F,Iwanaga T,Konishi F,Terada M,Wakasugi H

    更新日期:2002-01-15 00:00:00

  • Cancer immunotherapy using in vitro genetically modified targeted dendritic cells.

    abstract::Modest clinical outcomes of dendritic cell (DC) vaccine trials call for novel strategies. In this study, we have created a chimeric CD40 molecule that incorporates a single chain Fv (scFv) molecule specific for human ErbB2 antigen and fusing to the membrane spanning and cytosolic domains of murine CD40. After adenovir...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-6051

    authors: Wei H,Wang H,Lu B,Li B,Hou S,Qian W,Fan K,Dai J,Zhao J,Guo Y

    更新日期:2008-05-15 00:00:00

  • The octamer binding transcription factor Oct-1 is a stress sensor.

    abstract::The POU-domain transcription factor Oct-1 is widely expressed in adult tissues and has been proposed to regulate a large group of target genes. Microarray expression profiling was used to evaluate gene expression changes in Oct-1-deficient mouse fibroblasts. A number of genes associated with cellular stress exhibited ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-2399

    authors: Tantin D,Schild-Poulter C,Wang V,Haché RJ,Sharp PA

    更新日期:2005-12-01 00:00:00

  • Influence of bay-region methyl group on formation of 5-methylchrysene dihydrodiol epoxide:DNA adducts in mouse skin.

    abstract::The binding of tritium-labeled 5-methylchrysene to DNA of CD-1 mouse skin 24 hr after treatment has been studied. DNA was isolated from the treated skin areas of mice and hydrolyzed enzymatically to deoxyribonucleosides, and the hydrolysate was chromatographed on a Sephadex LH-20 column using a methanol:water gradient...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Melikian AA,LaVoie EJ,Hecht SS,Hoffmann D

    更新日期:1982-04-01 00:00:00

  • Kinetics of O6-methylguanine repair in human normal and ataxia telangiectasia cell lines and correlation of repair capacity with cellular sensitivity to methylating agents.

    abstract::Human lymphoblastoid cell lines from normal individuals and from patients with ataxia telangiectasia were either proficient or deficient in their ability to repair the mutagenic DNA adduct O6-methylguanine that is induced by methylating carcinogens. There was no relationship between the capacity to repair O6-methylgua...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Shiloh Y,Becker Y

    更新日期:1981-12-01 00:00:00

  • Loss of heterozygosity of chromosome 3p21 is associated with mutant TP53 and better patient survival in non-small-cell lung cancer.

    abstract::Allelic loss of chromosome region 3p21.3 occurs early and frequently in non-small-cell lung cancer, and numerous tumor suppressor genes at this locus may be targets of inactivation. Using an incident case series study of non-small-cell lung cancer, we sought to determine the prevalence of loss of heterozygosity (LOH) ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-2558

    authors: Marsit CJ,Hasegawa M,Hirao T,Kim DH,Aldape K,Hinds PW,Wiencke JK,Nelson HH,Kelsey KT

    更新日期:2004-12-01 00:00:00

  • Tumor angiogenesis and polyamines: alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits B16 melanoma-induced angiogenesis in ovo and the proliferation of vascular endothelial cells in vitro.

    abstract::alpha-Difluoromethylornithine (DFMO), an irreversible inhibitor of ornithine decarboxylase, inhibited B16 melanoma-induced angiogenesis in chick embryo chorioallantoic membrane and subsequently the growth of the tumor on the chorioallantoic membrane. These inhibitions were reversed by exogenous putrescine and spermidi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Takigawa M,Enomoto M,Nishida Y,Pan HO,Kinoshita A,Suzuki F

    更新日期:1990-07-01 00:00:00